Author profile
Pearce Wilcox, MD,
Current evidence-based guidelines, including those of the Canadian Thoracic Society,[1] advocate long-acting bronchodilators for symptomatic COPD patients and the combination of inhaled corticosteroids (ICS) and long-... Read More
Although many different factors may be involved in the development of COPD, smoking is the most significant. Exposure to tobacco smoke provokes a series of inflammatory processes involving the small as well as the large... Read More